BSG and colorectal carcinoma: Additionally, we demonstrated that targeting CD147 may be a promising strategy to increase 5-FU sensitivity in 5-FU-resistant CRC in vitro and in vivo. We found that AC-73, a small molecule CD147 inhibitor (48), reversed 5-FU resistance.